HRPT2, a tumor suppressor gene for hyperparathyroidism-jaw tumor syndrome

被引:21
作者
Wang, PF
Tan, MH
Zhang, C
Morreau, H
Teh, BT
机构
[1] Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI 49503 USA
[2] Alexandra Hosp, Dept Med, Singapore, Singapore
[3] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands
关键词
hyperparathyroidism-jaw tumor syndrome; HRPT2; parafibromin; parathyroid carcinoma;
D O I
10.1055/s-2005-870150
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hyperparathyroidism-jaw tumor (HPT-JT) syndrome is a familial multi-tumor syndrome resulting from inactivating mutations in the HRPT2 tumor suppressor gene, which encodes a protein product named parafibromin. Here, we will review recent advances in genetic and protein studies on parafibromin, and examine its biological functions.
引用
收藏
页码:380 / 383
页数:4
相关论文
共 50 条
[21]   In silico analysis of CDC73 gene revealing 11 novel SNPs with possible association to Hyperparathyroidism-Jaw Tumor syndrome [J].
Abdelmoneim, Abdelrahman H. ;
Mohammed, Alaa, I ;
Gadim, Esraa O. ;
Mohammed, Mayada Alhibir ;
Hamza, Sara H. ;
Mirghani, Sara A. ;
Mahmoud, Thwayba A. ;
Hassan, Mohamed A. .
EUROBIOTECH JOURNAL, 2020, 4 (02) :67-81
[22]   Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73 [J].
J-H Zhang ;
L M Panicker ;
E M Seigneur ;
L Lin ;
C D House ;
W Morgan ;
W C Chen ;
H Mehta ;
M Haj-Ali ;
Z-X Yu ;
W F Simonds .
Cell Death & Differentiation, 2010, 17 :1551-1565
[23]   Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73 [J].
Zhang, J-H ;
Panicker, L. M. ;
Seigneur, E. M. ;
Lin, L. ;
House, C. D. ;
Morgan, W. ;
Chen, W. C. ;
Mehta, H. ;
Haj-Ali, M. ;
Yu, Z-X ;
Simonds, W. F. .
CELL DEATH AND DIFFERENTIATION, 2010, 17 (10) :1551-1565
[24]   Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment [J].
F. Cetani ;
E. Pardi ;
E. Ambrogini ;
C. Banti ;
P. Viacava ;
S. Borsari ;
J. P. Bilezikian ;
A. Pinchera ;
C. Marcocci .
Journal of Endocrinological Investigation, 2008, 31 :900-904
[25]   Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment [J].
Cetani, F. ;
Pardi, E. ;
Ambrogini, E. ;
Banti, C. ;
Viacava, P. ;
Borsari, S. ;
Bilezikian, J. P. ;
Pinchera, A. ;
Marcocci, C. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2008, 31 (10) :900-904
[26]   A Novel Mutation in a Patient with Hyperparathyroidism-Jaw Tumour Syndrome [J].
Bellido, Virginia ;
Larranaga, Ihintza ;
Guimon, Maite ;
Martinez-Conde, Rafael ;
Eguia, Asier ;
Perez de Nanclares, Gustavo ;
Castano, Luis ;
Gaztambide, Sonia .
ENDOCRINE PATHOLOGY, 2016, 27 (02) :142-146
[27]   Hyperparathyroidism–jaw tumor syndrome: a report of three large kindred [J].
Maurizio Iacobone ;
Giulia Masi ;
Luisa Barzon ;
Andrea Porzionato ;
Veronica Macchi ;
Francesco Antonio Ciarleglio ;
Giorgio Palù ;
Raffaele De Caro ;
Giovanni Viel ;
Gennaro Favia .
Langenbeck's Archives of Surgery, 2009, 394 :817-825
[28]   Hyperparathyroidism - jaw tumor syndrome: a report of three large kindred [J].
Iacobone, Maurizio ;
Masi, Giulia ;
Barzon, Luisa ;
Porzionato, Andrea ;
Macchi, Veronica ;
Ciarleglio, Francesco Antonio ;
Palu, Giorgio ;
De Caro, Raffaele ;
Viel, Giovanni ;
Favia, Gennaro .
LANGENBECKS ARCHIVES OF SURGERY, 2009, 394 (05) :817-825
[29]   Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism [J].
Domingues, Rita ;
Tomaz, Rute Alexandra ;
Martins, Carmo ;
Nunes, Carla ;
Bugalho, Maria Joao ;
Cavaco, Branca Maria .
CLINICAL ENDOCRINOLOGY, 2012, 76 (01) :33-38
[30]   Identification of De Novo Germline Mutations in the HRPT2 Gene in Two Apparently Sporadic Cases with Challenging Parathyroid Tumor Diagnoses [J].
Branca Maria Cavaco ;
Rita Santos ;
Ana Félix ;
Davide Carvalho ;
José Manuel Lopes ;
Rita Domingues ;
Marta Sirgado ;
Nádia Rei ;
Fernando Fonseca ;
Jorge Rosa Santos ;
Luís Sobrinho ;
Valeriano Leite .
Endocrine Pathology, 2011, 22 :44-52